Skip to main content
Johnson & Johnson10-Q: Product liability

Recorded $5.5 billion charge for proposed talc ovarian litigation resolution

What happened

Johnson & Johnson recorded a charge of approximately $5.5 billion in Q3 and the fiscal nine months of 2026 related to the proposed talc ovarian litigation resolution. This substantial liability impacts corporate earnings and may drive legal, claims management, and compliance consulting needs.

Source

SEC EDGAROct 21, 2026

Quarterly report (Form 10-Q)

Johnson & Johnson 10-Q for Quarter ended Sep 27, 2026

Filing excerpt

The fiscal third quarter and nine months of 2026 includes a charge of approximately $5.5 billion related to the proposed talc ovarian litigation resolution and $1.0 billion of acquired in-process research and development expense related to the acquisition of Firefly Bio, Inc.

sec.gov/Archives/edgar/data/200406/000020040626000197/jnj-20260927.htmRead the full source

Other signals in this filing (7)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Product liability

What this signalsFilings often name leadership changes, deals and spending plans.

Period
Quarter ended Sep 27, 2026
Fiscal year end
09/27
Filed
Oct 21, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
$5.5B (charge related to proposed talc ovarian litigation resolution)

Details

CIK
200406
Accession number
0000200406-26-000197
Timeframe
Current quarter
Quarter
Q3
Filing year
2026
Period end date
Sep 27, 2026
Why it matters
Quality management needed
Signal category
Risk

Extraction

Confidence
High
Relevance
85%
Sentiment
Negative
Detected
Oct 27, 2026
signal_type
sec-10q
signal_subtype
productLiability

Use this data

Get every 10-Q signal for Johnson & Johnson and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Johnson & Johnson this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/3761c28c-6929-44c0-975c-c91c96f7fd8f returns this record as JSON. POST /v1/companies/enrich returns every signal for jnj.com.

{
  "signal_id": "3761c28c-6929-44c0-975c-c91c96f7fd8f",
  "signal_type": "sec-10q",
  "signal_subtype": "productLiability",
  "detected_at": "2026-10-27T08:04:17.626+00:00",
  "company": {
    "name": "Johnson & Johnson",
    "domain": "jnj.com"
  },
  "data": {
    "detail": "Johnson & Johnson recorded a charge of approximately $5.5 billion in Q3 and the fiscal nine months of 2026 related to the proposed talc ovarian litigation resolution. This substantial liability impacts corporate earnings and may drive legal, claims management, and compliance consulting needs.",
    "metrics": {
      "timeframe": "current_quarter",
      "dollar_context": "charge related to proposed talc ovarian litigation resolution",
      "dollar_millions": 5500
    },
    "quarter": "Q3",
    "summary": "Recorded $5.5 billion charge for proposed talc ovarian litigation resolution",
    "excerpts": "The fiscal third quarter and nine months of 2026 includes a charge of approximately $5.5 billion related to the proposed talc ovarian litigation resolution and $1.0 billion of acquired in-process research and development expense related to the acquisition of Firefly Bio, Inc.",
    "relevance": 0.85,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/200406/000020040626000197/jnj-20260927.htm",
    "filing_date": "2026-10-21",
    "filing_year": 2026,
    "fiscal_year": 2026,
    "fiscal_year_end": "09/27",
    "period_end_date": "2026-09-27",
    "sales_relevance": "Quality management needed",
    "signal_category": "risk"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.